These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8155839)

  • 41. Emergence of Shiga toxin 1 genes within Shigella dysenteriae type 4 isolates from travelers returning from the Island of Hispañola.
    Gupta SK; Strockbine N; Omondi M; Hise K; Fair MA; Mintz E
    Am J Trop Med Hyg; 2007 Jun; 76(6):1163-5. PubMed ID: 17556630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of Shiga toxin-producing Shigella species isolated from French travellers returning from the Caribbean: an emerging pathogen with international implications.
    Gray MD; Lacher DW; Leonard SR; Abbott J; Zhao S; Lampel KA; Prothery E; Gouali M; Weill FX; Maurelli AT
    Clin Microbiol Infect; 2015 Aug; 21(8):765.e9-765.e14. PubMed ID: 25980352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proposal to clone Shiga-like toxin gene from E. coli.
    Recomb DNA Tech Bull; 1984 Sep; 7(3):130-41. PubMed ID: 6393228
    [No Abstract]   [Full Text] [Related]  

  • 44. Cloning and expression of the genes specifying Shiga-like toxin production in Escherichia coli H19.
    Huang A; de Grandis S; Friesen J; Karmali M; Petric M; Congi R; Brunton JL
    J Bacteriol; 1986 May; 166(2):375-9. PubMed ID: 3009393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reconstitution of active recombinant Shiga toxin (Stx)1 from recombinant Stx1-A and Stx1-B subunits independently produced by E. coli clones.
    Nishikawa T; Fujii J; Yoshida S; Yutsudo T
    FEMS Microbiol Lett; 1999 Sep; 178(1):13-8. PubMed ID: 10483717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of iron and temperature on Shiga-like toxin I production by Escherichia coli.
    Weinstein DL; Holmes RK; O'Brien AD
    Infect Immun; 1988 Jan; 56(1):106-11. PubMed ID: 3121508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purification and crystallization of Shiga toxin from Shigella dysenteriae.
    Kozlov YV; Chernaia MM; Fraser ME; James MN
    J Mol Biol; 1993 Jul; 232(2):704-6. PubMed ID: 8345529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological detection assays for recombinant Shiga toxin &
    Gupta P; Dhaked RK
    Indian J Med Res; 2019 Mar; 149(3):412-417. PubMed ID: 31249208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit.
    Marcato P; Mulvey G; Read RJ; Vander Helm K ; Nation PN; Armstrong GD
    J Infect Dis; 2001 Feb; 183(3):435-43. PubMed ID: 11133375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.
    Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD
    Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Utilization of nylon membranes for the specific isolation of Escherichia coli O157 with DNA probes and checking for relationship to the shiga toxin Escherichia coli (STEC) group].
    Gallien P; Much C; Perlberg KW; Protz D
    Berl Munch Tierarztl Wochenschr; 1999 Feb; 112(2):58-63. PubMed ID: 10189723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis.
    Jackson MP; Wadolkowski EA; Weinstein DL; Holmes RK; O'Brien AD
    J Bacteriol; 1990 Feb; 172(2):653-8. PubMed ID: 2404947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.
    Wu T; Grassel C; Levine MM; Barry EM
    Infect Immun; 2011 Dec; 79(12):4912-22. PubMed ID: 21969003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Shiga toxin.
    Pugsley AP
    Microbiol Sci; 1986 Aug; 3(8):244-7. PubMed ID: 3153582
    [No Abstract]   [Full Text] [Related]  

  • 55. Molecular probe analysis of Shigella dysenteriae type 1 isolates from 1940 to 1987.
    Blaser MJ; Miotto K; Hopkins JA
    Int J Epidemiol; 1992 Jun; 21(3):594-8. PubMed ID: 1353066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identity of molecular structure of Shiga-like toxin I (VT1) from Escherichia coli O157:H7 with that of Shiga toxin.
    Takao T; Tanabe T; Hong YM; Shimonishi Y; Kurazono H; Yutsudo T; Sasakawa C; Yoshikawa M; Takeda Y
    Microb Pathog; 1988 Nov; 5(5):57-69. PubMed ID: 3070268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1.
    Fontaine A; Arondel J; Sansonetti PJ
    Infect Immun; 1988 Dec; 56(12):3099-109. PubMed ID: 3053452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential virulence of viable but nonculturable Shigella dysenteriae type 1.
    Rahman I; Shahamat M; Chowdhury MA; Colwell RR
    Appl Environ Microbiol; 1996 Jan; 62(1):115-20. PubMed ID: 8572688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and purification of Shiga-like toxin II B subunits.
    Acheson DW; De Breucker SA; Jacewicz M; Lincicome LL; Donohue-Rolfe A; Kane AV; Keusch GT
    Infect Immun; 1995 Jan; 63(1):301-8. PubMed ID: 7806370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity.
    Weinstein DL; Jackson MP; Perera LP; Holmes RK; O'Brien AD
    Infect Immun; 1989 Dec; 57(12):3743-50. PubMed ID: 2807546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.